Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Non-malignant Disease
Is there any experience treating Bizarre Parosteal Osteochondromatous Proliferation (BPOP) with adjuvant radiation?
Related Questions
Would you offer definitive radiation therapy for an extracranial schwannoma located in the pelvis?
Have you found radiation to be helpful in the management of xanthogranuloma?
Would you consider using LDRT for joint pain/arthritis caused by aromatase inhibitors as a means to keep patients on therapy?
Would you have any concerns about giving radiation therapy to a patient on isotretinoin (Accutane)?
Would you offer radiotherapy for a symptomatic large intraorbital venous-lymphatic malformation that is non-operable?
How would you treat a perineural IgG4-RD with persistent paresthesia?
What radiation dose would you use to treat a symptomatic osseous lesion secondary to AL-amyloidosis?
How would you approach a patient over the age of 40 with a sub-totally resected frontal oligodendroglioma, WHO Grade II, 1p/19q co-deleted, IDH mutant, with imaging concerning for second site in the pontomedullary junction?
Given the findings of SUNSET, demonstrating 60 Gy in 8 fractions to be a safe and effective regimen for ultracentral lesions, in what situations would you elect to use a 10 fraction hypofractionated regimen?
What dose and fractionation would you use for Kaposi’s sarcoma of the tonsil post op?
